Oxford BioMedica's market cap is currently $549.00M. The company's EPS TTM is $-1.811; its P/E ratio is ―; Oxford BioMedica is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 89.54M	£ 139.99M	£ 142.80M	£ 87.73M	£ 64.06M
Gross Profit	£ 39.73M	£ 69.18M	£ 82.64M	£ 46.07M	£ 28.34M
Operating Income	£ -184.17M	£ -51.56M	£ 20.77M	£ -4.83M	£ -12.58M
EBITDA	£ -148.62M	£ -10.86M	£ 33.22M	£ 3.92M	£ -9.60M
Net Income	£ -157.49M	£ -45.16M	£ 19.01M	£ -6.25M	£ -16.07M
Balance Sheet
Cash & Short-Term Investments	£ 103.72M	£ 141.31M	£ 109.02M	£ 46.98M	£ 18.96M
Total Assets	£ 252.34M	£ 460.18M	£ 237.23M	£ 183.93M	£ 122.93M
Total Debt	£ 111.46M	£ 114.28M	£ 9.34M	£ 13.85M	£ 8.39M
Net Debt	£ 7.74M	£ -27.00M	£ -99.60M	£ -32.90M	£ -7.85M
Total Liabilities	£ 174.51M	£ 223.99M	£ 49.89M	£ 71.18M	£ 47.30M
Stockholders' Equity	£ 74.01M	£ 204.65M	£ 187.34M	£ 112.75M	£ 75.63M
Cash Flow
Free Cash Flow	£ -38.35M	£ -28.91M	£ 15.99M	£ -10.24M	£ -29.28M
Operating Cash Flow	£ -28.52M	£ -12.62M	£ 25.45M	£ 3.12M	£ -3.51M
Investing Cash Flow	£ 2.81M	£ -56.46M	£ -9.46M	£ -10.80M	£ -19.40M
Financing Cash Flow	£ -12.70M	£ 98.62M	£ 46.21M	£ 38.19M	£ 6.91M

Currency in GBP

Oxford BioMedica Earnings and Revenue History

Income Statement >

Oxford BioMedica Debt to Assets

Balance Sheet >

Oxford BioMedica Cash Flow

Cash Flow >

Oxford BioMedica Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing